CDK-IN-14 (B34) is a CDK2 inhibitor (IC50=0.097 µM) with anti-hepatocellular carcinoma activity. CDK-IN-14 blocks the cell cycle of HepG-2 cancer cells through a caspase-mediated mechanism and induces apoptosis[1].
Molecular Weight:
545.00
Formula:
C30H26ClFN4O3
Target:
Apoptosis,Caspase,CDK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
